Skip to main content
ClearIPO

Molbio Diagnostics Limited

Mainboard IPO

ListedMainboardRisk-factor review pending

Risk analysis not yet reviewed. ClearIPO publishes risk factors only after a manual review of the offer document.

Last updated 12 Aug 2026

Key details

Price band
₹768 to ₹807
Face value
Rs 10
Lot size
18 shares
Minimum investment
Rs 14,526
Issue size
Rs 940 Cr
Fresh issue
Rs 940 Cr
Retail quota
35%
Exchanges
BSE, NSE
Opening date
10 Aug 2026
Closing date
12 Aug 2026
Allotment date
13 Aug 2026
Listing date
17 Aug 2026

3 further details have not been reported for this issue yet, so they are left out rather than estimated.

Explain this IPO simply

The same information as the prospectus, written the way you would explain it to a friend.

What the company does

Molbio Diagnostics is a point-of-care diagnostics company that develops and manufactures healthcare technologies for diagnosing infectious and non-communicable diseases. The company’s core business revolves around its proprietary ‘Truenat’ platform, a portable, battery-operated polymerase chain reaction (PCR) system designed for use in resource-limited settings. This platform provides rapid and accurate test results within approximately one hour. The company’s primary source of revenue is the sale of its ‘Truenat’ devices and the recurring sale of compatible, disease-specific micro-PCR test kits. Molbio offers a wide range of tests for various infectious diseases, including tuberculosis, COVID-19, Hepatitis B and C, HIV, and HPV. Through its subsidiaries, the company also provides devices related to radiology and digital pathology. Discuss on Trading Q&A

No hand-checked analysis for this issue yet

We publish only the figures our data source reports for this IPO. Clarity scoring, strengths and risks, use of funds and valuation multiples appear here once the prospectus has been read and verified.

Subscription status

Not reported

Final subscription figures were not reported by the source.

Grey market premium

Unofficial and unregulated

Grey market premium is unofficial, unregulated, and can change quickly. It should not be treated as a guaranteed listing price.
Current GMP
Rs 130
Previous GMP
Rs 130
Indicative level only
Rs 937

Updated 2026-08-15T13:57:35.866Z. Source: IPO Watch grey market tracker, not an exchange or regulator. Figures are checked against this IPO's issue price before publication.

Important documents

IPO timeline

  1. IPO opens

    10 Aug 2026

    First day you can apply.

  2. IPO closes

    12 Aug 2026

    Last day to apply, usually by evening.

  3. Allotment

    13 Aug 2026

    Who gets shares is decided.

  4. Refund / unblock

    14 Aug 2026

    Blocked money is released if you did not get shares.

  5. Shares in demat

    14 Aug 2026

    Allotted shares reach your demat account.

  6. Listing day

    17 Aug 2026

    Shares start trading on the exchange.

Frequently asked questions

Where this information comes from

Last updated
2026-08-12T11:00:04.395Z
Last verified
2026-08-12T11:00:04.395Z
Primary source
bse
Secondary source
Exchange filings
Report incorrect information